Discovery Life Sciences’ Acquisition Of Targos Molecular Pathology GmbH

CMS advised Discovery Life Sciences on the deal.

The US-American biosample and biomarker specialist Discovery Life Sciences has taken over Targos Molecular Pathology GmbH. The acquisition of one of the largest molecular pathology laboratories in Europe marks the first transaction of its kind in Germany for Discovery. With the acquisition, Discovery Life Sciences is expanding its role as a global service provider for the development of tissue biomarkers, the support of clinical studies and clinical pathological training courses close to the market. All parties involved have agreed not to disclose the details of the transaction.

Discovery Life Sciences, based in Huntsville, Alabama (USA), claims to combine the world’s largest commercial biosample inventory and procurement network with numerous multi-active biomarker service laboratories to accelerate precision medicine programs for cancer, infectious diseases and other complex diseases.

Targos Molecular Pathology GmbH, based in Kassel, has been offering highly standardized development and use of clinical biomarkers for the international pharmaceutical and diagnostics industry for more than 15 years. The company will integrate and standardize its operations into a single global scientific team through the transaction with Discovery’s North American IHC and pathology laboratories.

The CMS team included Dr. Igor Stenzel (Picture), Lead Partner, Berlin, Patrick M Lühr, Counsel, Berlin, Fabian Mayer, Senior Associate, Berlin, Olena Mausolf, Legal Consultant, Berlin, Anke Clippingdale, Legal Consultant, Berlin, Birgit Wagner, Senior Legal Consultant, Berlin, all Corporate/M&A, Dr. Roland Wiring, Partner, Hamburg, Dr. Huy Do Chi, Senior Associate, Berlin, Dr. Elisa Fontaine, Associate, Hamburg, all Intellectual Property, Dr. Sören Langner, Partner, Berlin, Dr. Andres Hofelich, Partner, Köln, Dr. Henrike Seifert, Senior Associate, Berlin, Neil Yeats, Senior Associate, Berlin, Dr. Richard Lauer, Associate, Köln, all Labor, Employment & Pensions, Alexander Schmitt, Counsel, Berlin, Conrad Gräwe, Legal Consultant, Berlin, both Banking, Finance & Insurance, Dr. Rolf Hempel, Partner, Stuttgart, Roxana Mina Kruse, Senior Associate, Brüssel, Angelika Wieczorkowski, Senior Associate, Stuttgart, all Competition & EU, Thomas Gerdel, Partner, Düsseldorf, Dr. Martin Friedberg, Counsel, Düsseldorf, both Tax law.

Involved fees earner: Huy Do Chi – CMS Hasche Sigle; Elisa Fontaine – CMS Hasche Sigle; Martin Friedberg – CMS Hasche Sigle; Thomas Gerdel – CMS Hasche Sigle; Rolf Hempel – CMS Hasche Sigle; Andreas Hofelich – CMS Hasche Sigle; Roxana Kruse – CMS Hasche Sigle; Sören Langner – CMS Hasche Sigle; Richard Lauer – CMS Hasche Sigle; Patrick Lühr – CMS Hasche Sigle; Fabian Mayer – CMS Hasche Sigle; Alexander Schmitt – CMS Hasche Sigle; Henrike Seifert – CMS Hasche Sigle; Igor Stenzel – CMS Hasche Sigle; Angelika Wieczorkowski – CMS Hasche Sigle; Roland Wiring – CMS Hasche Sigle; Neil Yeats – CMS Hasche Sigle;

Law Firms: CMS Hasche Sigle;

Clients: Discovery Life Sciences;

Author: Federica Tiefenthaler